arrow
H

Hans-Heinrich Hoffmann

rockefeller university
H指数:42
被引数:1.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A Novel Chemotype of Orally Active SARS-CoV-2 NSP14 Methyltransferase Inhibitors

一种新型的口服活性SARS-CoV-2 NSP14甲基转移酶抑制剂

2026-01-010
OA
Small-molecule inhibition of SARS-CoV-2 NSP14 RNA cap methyltransferase

小分子抑制SARS-CoV-2 NSP14 RNA帽甲基转移酶

Nature
IF48.5
2024-12-110
PRE
Human antibodies in Mexico and Brazil neutralizing tick-borne flaviviruses

墨西哥和巴西的人类抗体中和蜱传黄病毒

2024-06-010
OA
Heteromultimeric sarbecovirus receptor binding domain immunogens primarily generate variant- specific neutralizing antibodies
2023-12-141
OAAI
IL-6/STAT3 axis dictates the PNPLA3-mediated susceptibility to non-alcoholic fatty liver disease

IL-6/STAT3轴决定了非酒精性脂肪性肝病的PNPLA3-mediated易感性

2023-01-0150
OAAI
Analysis of memory B cells identifies conserved neutralizing epitopes on the N-terminal domain of variant SARS-Cov-2 spike proteins
IMMUNITY
IF26.3
2022-06-0171
OAAI
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies

新型冠状病毒肺炎死亡的风险更大,并且与I型IFN自身抗体的年龄有关

2022-05-16119
OA
Autoantibodies neutralizing type I IFNs are present in ∼4% of uninfected individuals over 70 years old and account for ∼20% of COVID-19 deaths

中和I型干扰素的自身抗体存在于70岁以上未感染者的4% 中,占新型冠状病毒肺炎死亡的20%

2021-08-10407
OAAI
Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccine
2021-02-05142
OAAI
Enhanced SARS-CoV-2 neutralization by dimeric IgA
2021-01-20349
OAAI